Home

"We perform gene editing in primary human immune cells for basic research, drug discovery, and to develop new cell therapies. Cergentis has helped us characterize the on- and off-target integrations when non-virally targeting new genetic material into human T cells with CRISPR, aiding our push towards clinical translation."

"TLA has become an indispensable tool to characterize transgene insertion events and complex gene targeting approaches."

"TLA analysis has proven to be very useful to quality control genetically engineered cell lines”